I. Squire

发表

Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

I. Squire, L. Ng, J. Davies, 2000, Heart.

Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.

D. Barnett, I. Squire, L. Ng, 2000, European heart journal.

Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning.

M. Galiñanes, S. Ghosh, L. Ng, 2000, Cardiovascular Research.

Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction.

D. Barnett, I. Squire, L. Ng, 1999, Clinical science.

The Cardiac Insufficiency Bisoprolol Study II

I. Squire, G. Drummond, 1999, The Lancet.

Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population.

D. Barnett, I. Squire, L. Ng, 1999, European heart journal.

Prolonged stability of endogenous cardiotrophin-1 in whole blood.

L. Ng, J. Davies, S. Talwar, 2001, Metabolism: clinical and experimental.

Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction.

L. Ng, R. O'brien, J. Davies, 2000, Clinical science.

An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction

L. Ng, J. Davies, S. Talwar, 1999 .

Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction

D. Barnett, L. Ng, J. Davies, 1999 .

An immunoluminometric assay for N-terminal pro-brain natriuretic peptide: development of a test for left ventricular dysfunction.

I. Squire, L. Ng, J. Davies, 1999, Clinical science.

An immunoluminometric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure.

J. Davies, D. Barnett, L. Ng, 1999, Biochemical and biophysical research communications.

Reduction in plasma concentrations of N terminal pro B type natriuretic peptide following percutaneous coronary intervention

C. Daly, K. Fox, P. Kalra, 2004, Heart.

THE CARDIAC INSUFFICIENCY BISOPROLOL STUDY II. AUTHORS' REPLY

P. Poole‐Wilson, A. Segev, H. Dargie, 1999 .

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Neuromuscular blocking and autonomic effects of vecuronium and atracurium in the anaesthetized cat.

I. Squire, I. G. Marshall, A. J. Gibb, 1983, British journal of anaesthesia.

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)

P. Ponikowski, S. Solomon, M. Pfeffer, 2013, European journal of heart failure.

Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.

L L Ng, S Talwar, P F Downie, 2000, British journal of clinical pharmacology.